Approval granted for change in Humate-P storage.
The FDA has approved changes to the labeling of antihemophilic factor/von Willebrand factor complex (human) (Humate-P, CSL Behring) following review of stability data submitted by the manufacturer. The agency determined that
Q&A: How Specific GLP-1s Impact Different Patient Populations | ASHP Midyear
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.